Listed German private-equity firm tumbles after Gotham City short-sale report
By Steve Goldstein
Shares of Mutares tumbled Thursday after the publication of a short-selling report on the German private-equity investor that seeks to turn around medium-sized companies.
Mutares shares (XE:MUX) dived as much as 28% after Gotham City Research alleged accounting irregularities and said the company appears increasingly reliant on debt. In late trade, Mutares stock fell by 14%.
Mutares shares dropped 8% on Wednesday when Gotham City's General Industrial Partners disclosed a short position in the company.
Mutares said it was a one-sided interpretation of its strategy and business transactions, as it highlighted successful exits of more than EUR200 million between 2022 and 2024. It also said it prepares and publishes financial information in accordance with legal requirements and that it is "convinced" it will meet its dividend guidance for the current financial year.
The Munich company, which is due to hold a capital markets day next month, said it will publish a further detailed response in due course.
In the first half of the year, Gotham City's short calls ranked it among the top 10 of activist short-sellers, according to Breakout Point.
-Steve Goldstein
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-26-24 1135ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk